“Safety and Efficacy of Risankizumab in the Treatment of Chronic Plaque-Type Psoriasis: A Pilot Single-Arm, Single-Center, Prospective Cohort Study” (2025) Bangladesh Armed Forces Medical Journal, 58(1), pp. 22–29. doi:10.3329/bafmj.v58i1.84958.